Clearing up the smoke: Physical and mental health considerations regarding cannabis use in adolescents with cystic fibrosis. Issue 2 (18th November 2022)

• Record Type: Journal Article
• Authors: Ince, H. Yavuz; Phan, Hanna; Nasr, Samya Z.; Pierce, Jessica M.; Malas, Nasuh
• Is Part Of: Pediatric pulmonology. Volume 58:Issue 2(2023)
• Page Start: 398
• Page End: 407
• Publication Date: 2022-11-18
• Subjects: cannabis -- counseling -- cystic fibrosis -- mental health; Pediatric respiratory diseases -- Periodicals; Pediatrics -- Periodicals; 618.922
• DOI: 10.1002/ppul.26241
• Languages: English
• ISSNs: 8755-6863

Abstract

Abstract: The cannabis plant is the most used federally illegal drug in the United States and is widely used by adolescents. Cannabis has complex effects on the body and mind. All health professionals who take care of adolescents with cystic fibrosis (CF) should be aware of the factors impacting cannabis use in CF. Given limited evidence regarding the benefits of cannabis and the significant risks, clinicians have the responsibility to identify risk of cannabis use early, counsel patients about the risks, provide a safe space for ongoing conversations about cannabis use in the context of CF care, and deliver evidence‐based interventions.